Latest Breaking News On - Specialty generics - Page 24 : comparemela.com

Specialty Generics Market to Enjoy Explosive Growth | Teva Pharmaceutical Ltd, Novartis, Mylan NV, Pfizer Inc

Specialty Generics Market to Enjoy Explosive Growth | Teva Pharmaceutical Ltd, Novartis, Mylan NV, Pfizer Inc
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

United statesValeant pharmaceuticals international incTuring pharmaceuticalsPorter fiverGlobal specialty generics market researchSee campaignResearch newswirePfizer incTeva pharmaceutical ltdProduct service offeringsBrowse premium researchSpecialty genericsReport oceanIncluding fullRecovery timelineFree sample copy

New Guidebook for Caregivers of Children with Rare and/or Serious Illnesses

New Guidebook for Caregivers of Children with Rare and/or Serious Illnesses
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesHong kongNew zealandKimberly haugstadJannie kennedyKathryn devannyLeslie urdanetaChris feudtnerMelisa lopezLauriej turnerMousumi boseMegan thomas hebdonTheresaj smithJennifer siedmanEllen miller sonet

Mallinckrodt Announces Publication of Phase 3 STRATA2016 Study in Burns

Mallinckrodt Announces Publication of Phase 3 STRATA2016 Study in Burns
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesSteven romanoBen ricklesDanielj specialePrnewswire mallinckrodtJamesh holmesMallinckrodt pharmaceuticalsStratatech corporationWake forest school of medicineGovernment accountability officeInternational society for burn injuriesUnited states government accountability officeBiomedical advanced researchHuman servicesUs department of healthDrug administration

Mallinckrodt Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection) in New European Respiratory Society (ERS) Treatment Guidelines for Patients with Pulmonary Sarcoidosis

Mallinckrodt Announces Inclusion of Acthar® Gel (Repository Corticotropin Injection) in New European Respiratory Society (ERS) Treatment Guidelines for Patients with Pulmonary Sarcoidosis
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesSteven romanoDanielj specialePrnewswire mallinckrodtMark tyndallRobert baughmanMallinckrodt pharmaceuticalsCounsel government affairsDrug administrationExchange commissionUs sarcoidosis expert panel consensus statementGovernment affairsEuropean respiratory societyGreen room communicationsPulmonologist at university of cincinnati health

Mallinckrodt Announces U S FDA Approval of StrataGraft® (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen

Share this article Share this article DUBLIN, June 15, 2021 /PRNewswire/ Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved StrataGraft ® (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) for the treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns). Please see Important Safety Information for StrataGraft below. Experience the interactive Multichannel News Release here: This project was funded in part with $86 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), under contract HHSO100201500027 for Stratatech Corporation, a Mallinckrodt company, to develop StrataGraft.

United statesSteven romanoBen ricklesDanielj specialeRon bartlettMark tyndallGary disbrowMallinckrodt pharmaceuticalsStratatech corporationRegional burn center at baton rouge generalUnited states government accountability officeBiomedical advanced researchHuman servicesCounsel government affairsUs department of healthDrug administration